Identification |
Name: | Alizapride hydrochloride |
Synonyms: | 1H-Benzotriazole-5-carboxamide,6-methoxy-N-[[1-(2-propenyl)-2-pyrrolidinyl]methyl]-, monohydrochloride (9CI);Nausilen;Plitican;Vergentan;1H-Benzotriazole-5-carboxamide,6-methoxy-N-[[1-(2-propen-1-yl)-2-pyrrolidinyl]methyl]-, hydrochloride (1:1); |
CAS: | 59338-87-3 |
EINECS: | 261-710-6 |
Molecular Formula: | C16H21N5O2.HCl |
Molecular Weight: | 351.83 |
InChI: | InChI=1S/C16H21N5O2.ClH/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2;/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20);1H |
Molecular Structure: |
|
Properties |
Density: | 1.224 g/cm3 |
Appearance: | COA |
Specification: | usageEng:Alizapride is a dopamine antagonist with prokinetic and antiemetic effects. Alizapride is used in t he treatment of post-operative nausea and vomitting. |
Usage: | Alizapride is a dopamine antagonist with prokinetic and antiemetic effects. Alizapride is used in t he treatment of post-operative nausea and vomitting. |
Safety Data |
|
|